Opinion
2017-2121
11-14-2017
UNITED THERAPEUTICS CORPORATION, Appellant v. STEADYMED LTD., Appellee
STEPHEN MAEBIUS, Foley & Lardner LLP, Washington, DC, argued for appellant. Also represented by GEORGE ELLSWORTH QUILLIN; DOUGLAS H. CARSTEN, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA; ROBERT DELAFIELD, Austin, TX; SHAUN R. SNADER, United Therapeutics Corporation, Washington, DC. STUART ERIC POLLACK, DLA Piper US LLP, New York, NY, argued for appellee. Also represented by LISA ANNE HAILE, STANLEY JOSEPH PANIKOWSKI, III, San Diego, CA.
NOTE: This disposition is nonprecedential. Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016-00006.
JUDGMENT
STEPHEN MAEBIUS, Foley & Lardner LLP, Washington, DC, argued for appellant. Also represented by GEORGE ELLSWORTH QUILLIN; DOUGLAS H. CARSTEN, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA; ROBERT DELAFIELD, Austin, TX; SHAUN R. SNADER, United Therapeutics Corporation, Washington, DC. STUART ERIC POLLACK, DLA Piper US LLP, New York, NY, argued for appellee. Also represented by LISA ANNE HAILE, STANLEY JOSEPH PANIKOWSKI, III, San Diego, CA. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (PROST, Chief Judge, WALLACH and HUGHES, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT November 14, 2017
Date
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court